Skip to main content
. Author manuscript; available in PMC: 2016 Nov 21.
Published in final edited form as: Annu Rev Med. 2015 Aug 26;67:467–486. doi: 10.1146/annurev-med-111314-033712

Table 2.

Tobacco addiction medication pipeline

In drug development In Phase II trials Tried and failed

atomoxetine, N-acetylcysteine, tiagabine, vigabatrin baclofen, carvedilol, d-cycloserine, labetalol, lorcanserin, topiramate buspirone, EVT 302, GSK598809, lobeline, mecamylamine, menthyl valerate/eucalyptus oil/camphor/quinine (nicobrevin), naltrexone, reboxetine, rimonabant, selegiline silver acetate, surinabant, vaccines